We are dedicated to serving emerging biotech companies, accelerating drug development by connecting them with top-tier experts, and ensuring seamless access to both healthy volunteers and patients. Strategically located within the heart of a public tertiary clinic, our Phase I unit provides unparalleled support in advancing clinical research.
Where Everything Begins in Clinical Drug Development
Accelsiors combines scientific rigor and patient-centered care, executing Phase II studies to the highest standards for your product’s success. Our Phase II trials bridge early and late-stage development, focusing on dosage, safety, and efficacy. With our hospital-based infrastructure in Thessaloniki, Greece, we offer access to diverse patient pools and integrated environments for dose-ranging studies. Our experienced team ensures real-time safety monitoring, precision dosing, and innovative practices to enhance patient engagement and provide reliable data.
Accelsiors site management qualified monitoring, local knowledge, and proactive risk management to ensure success in clinical trials. Our global presence and centralized Regulatory Affairs unit, supported by local specialists, guarantee adherence to national/international regulations, directives, and laws. We are a truly scientifically and quality-driven CRO. We not only monitor a study, but we ensure that our subject matter experts are optimally driving the study from design to execution.
Advanced Capabilities for Optimized Clinical Trials
Accelsiors optimizes early trials with PK/PD expertise, advanced analytics, rapid recruitment, and streamlined processes for fast, reliable results.
Tailored Solutions for Biotech Companies
Customized services for biotech firms, a tertiary clinic, and rapid access to healthy volunteers and specialized patient populations.
Regulatory & Ethical Expertise
Dedicated regulatory unit guides sponsors through clinical and ethical approvals, ensuring compliance, patient safety, and data integrity.
Dedicated Team with Proven Experience
Our industry knowledge and experienced professionals ensure reliable management of your clinical trial.
Download our white paper and get access to downloadable resources.
When working with our Phase I Unit, there is a synergy in our work, as we understand the unique challenges faced by the biotech companies in bringing new therapies to market. Our drive for innovation in early-phase clinical research by providing tailored solutions is our sole mission. At Accelsiors we streamline every bit of your clinical journey: from participant recruitment to the latest facilities and expert consulting. In doing so, we not only ensure, but also enable you to focus on what is most important for you: advancing science and improving lives
- Comprehensive Expertise: A full suite of services spanning study design, participant recruitment, safety assessments, and data management.
- Tailored Solutions: Strategies customized to your therapeutic area and development goals.
- Accelerated Timelines: Integrated processes and innovative methodologies to optimize every clinical research phase.
- Global Standards: Compliance with international regulatory frameworks, ensuring your trial is market-ready.
- Collaborative Partnerships: Access to a network of local experts, patient organizations, and regulatory authorities.
- Adaptive Methodologies: Tailored trial designs that respond to emerging data and evolving needs.
- Participant-centric strategies: Efficient recruitment, retention, and engagement to optimize trial outcomes.
- Integrated Processes: End-to-end solutions that unify recruitment, safety, data management, and consultancy.
- Data-Driven Insights: Leveraging analytics to refine strategies and make smarter decisions.
- Collaborative Partnerships: Working alongside sponsors, patient organizations, and regulatory authorities to drive success.
- Fully implementing the Quality by Design approach.
The Acclesiors approach combines advanced methodologies, leading technologies, and true scientific expertise across various therapeutic areas. Furthermore, the strong focus on sleek integration, designs which easily adapt to your needs, and our participant-centric approach, we make sure your clinical program is accelerated, whilst maintaining what is important: high quality and compliance standards. Two things set us apart: a collaborative approach, as we are partners, and an unquestionable dedication to success in everything we do. These two pillars ensure we transform challenges into opportunities, and as such Accelsiors delivers solutions that streamline development and maximize the potential for your breakthrough therapies.
